Search Results - "Parize, Perrine"

Paralytic rabies outbreak mimicking guillain–Barré syndrome in French Amazonia.

Authors: Deschamps, Nathalie Mayence, Claire Parize, Perrine et al.

Source: PLoS Neglected Tropical Diseases. 3/30/2026, Vol. 20 Issue 3, p1-15. 15p.

Circumstances of Human–Bat interactions and risk of lyssavirus transmission in metropolitan France.

Authors: Parize, Perrine Travecedo Robledo, Isabel Cristina Cervantes‐Gonzalez, Minerva et al.

Source: Zoonoses & Public Health. Nov2020, Vol. 67 Issue 7, p774-784. 11p.

Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience.

Authors: Parize, Perrine Boussaud, Veronique Poinsignon, Vianney et al.

Source: Transplant Infectious Disease. Oct2017, Vol. 19 Issue 5, pn/a-N.PAG. 8p.

COVID-19-related travel restrictions temporarily reduced the demand for rabies post-exposure prophylaxis in France.

Authors: Parize, Perrine Poujol, Philippe Conan, Pierre Louis et al.

Source: Journal of Travel Medicine. Oct2021, Vol. 28 Issue 7, p1-3. 3p.

Immune response to rabies post-exposure prophylaxis in patients with non-HIV secondary immunodeficiencies.

Authors: Parize, Perrine Poujol, Philippe Morineau Le Houssine, Pascale et al.

Source: Vaccine. Jul2020, Vol. 38 Issue 33, p5091-5094. 4p.

Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis.

Authors: Parize, Perrine Billaud, Sandrine Bienvenu, Anne L. et al.

Source: Journal of Cystic Fibrosis. Dec2014, Vol. 13 Issue 6, p667-673. 7p.

Breaking the under-reporting cycle for zoonotic diseases in low-income and middle-income countries through national-level integration of community-based surveillance and response: insights from Cameroon, Chad, Côte d'Ivoire, and Mali.

Authors: Worsley-Tonks, Katherine E L Abakar, Mahamat Fayiz Coulibaly, Zanan et al.

Source: Lancet Infectious Diseases. Apr2026, Vol. 26 Issue 4, pe245-e258. 14p.

Transition écologique hospitalière : présentation du guide de déprescription des examens biologiques.

Authors: Costedoat-Chalumeau, Nathalie Bortolotti, Véronique Michon, Adrien et al.

Source: Revue de Médecine Interne. Feb2026, Vol. 47 Issue 2, p61-64. 4p.

Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study.

Authors: Melenotte, Cléa Chavarot, Nathalie L'Honneur, Anne-Sophie et al.

Source: Open Forum Infectious Diseases. Feb2024, Vol. 11 Issue 2, p1-10. 10p.

Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study.

Authors: Poline, Julie Postaire, Martine Parize, Perrine et al.

Source: European Journal of Clinical Microbiology & Infectious Diseases. May2021, Vol. 40 Issue 5, p1039-1048. 10p.

Devastating Gynecological Infections in Women with STAT3 Deficiency.

Authors: Redor, Alexis Danion, François Parize, Perrine et al.

Source: Clinical Infectious Diseases. Oct2020, Vol. 71 Issue 7, pe186-e190. 5p.

Oral switch therapy for paediatric Staphylococcus aureus bloodstream infections: A retrospective study in a tertiary hospital.

Authors: Attaianese, Federica Benhard, Johan Cohen, Jérémie F. et al.

Source: International Journal of Infectious Diseases. Jun2026, Vol. 167, pN.PAG-N.PAG. 1p.

Successful treatment with rezafungin after micafungin for relapsing Rasamsonia argillacea species complex pneumonia in a patient with bronchiectasis: A case report.

Authors: Bes-Berlandier, Hugo Coron, Noémie Pottier, Heloise et al.

Source: International Journal of Infectious Diseases. Mar2026, Vol. 164, pN.PAG-N.PAG. 1p.

Human rabies in Avignon, France, following exposure in Morocco, 2025.

Authors: Law Wun, Maria Grandbesançon, David Cano, Philippe et al.

Source: International Journal of Infectious Diseases. Feb2026, Vol. 163, pN.PAG-N.PAG. 1p.

Penetration of isavuconazole into the epithelial lining fluid of patients with pulmonary fungal infections. Comment on: 'Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions'.

Authors: Maillard, Alexis Bournaud, Léo Froelicher Pastre, Jean et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Sep2024, Vol. 79 Issue 9, p2403-2405. 3p.

Advances in antibacterial treatment of adults with high-risk febrile neutropenia.

Authors: Contejean, Adrien Maillard, Alexis Canouï, Etienne et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Sep2023, Vol. 78 Issue 9, p2109-2120. 12p.

Success and limitations of the French public health strategy after 2 years of large implementation of respiratory syncytial virus prophylaxis: experience of a tertiary hospital (2018-2025).

Authors: Veyrenche, Nicolas Toubiana, Julie Chappuy, Hélène et al.

Source: International Journal of Infectious Diseases. Nov2025, Vol. 160, pN.PAG-N.PAG. 1p.

COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection.

Authors: Boudhabhay, Idris Serris, Alexandra Servais, Aude et al.

Source: Nephrology Dialysis Transplantation. Jul2022, Vol. 37 Issue 7, p1357-1365. 9p.

Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France.

Authors: Fourgeaud, Jacques Toubiana, Julie Chappuy, Hélène et al.

Source: European Journal of Clinical Microbiology & Infectious Diseases. Nov2021, Vol. 40 Issue 11, p2389-2395. 7p.

Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.

Authors: Contejean, Adrien Leporrier, Jérémie Canouï, Etienne et al.

Source: Clinical Infectious Diseases. 01/15/2021, Vol. 72 Issue 2, p257-264. 8p.